357
Views
12
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

A Multivalent and Thermostable Nanobody Neutralizing SARS-CoV-2 Omicron (B.1.1.529)

, , ORCID Icon, , , ORCID Icon, , , & show all
Pages 353-367 | Received 23 Aug 2022, Accepted 20 Dec 2022, Published online: 19 Jan 2023

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Ni Meng, Xiaolong Cheng, Mengyao Sun, Yushan Zhang, Xueke Sun, Xifu Liu & Jing Chen. (2023) Screening, Expression and Identification of Nanobody Against Monkeypox Virus A35R. International Journal of Nanomedicine 18, pages 7173-7181.
Read now

Articles from other publishers (11)

Hechao Zhu, Xinxin Li, Xiangmin Li, Huanchun Chen & Ping Qian. (2024) Protection against the H1N1 influenza virus using self-assembled nanoparticles formed by lumazine synthase and bearing the M2e peptide. Virology 597, pages 110162.
Crossref
Kush K. Pandey, Bikash R. Sahoo & Asit K. Pattnaik. (2024) Protein Nanoparticles as Vaccine Platforms for Human and Zoonotic Viruses. Viruses 16:6, pages 936.
Crossref
Fernando Merwaiss, Enrique Lozano‐Sanchez, João Zulaica, Luciana Rusu, Marta Vazquez‐Vilar, Diego Orzáez, Guillermo Rodrigo, Ron Geller & José‐Antonio Daròs. (2023) Plant virus‐derived nanoparticles decorated with genetically encoded SARS‐CoV‐2 nanobodies display enhanced neutralizing activity. Plant Biotechnology Journal 22:4, pages 876-891.
Crossref
Haozhen Yan, Yuanli Peng, Jinsong Zhang, Ruihao Peng, XiangNing Feng, JiaYue Su, HuaiMin Yi, Yuying Lu, Shan Gao, Jinsong Liu, Mingwei Yang, Xinrui Liu, Shenyang Gao & Zeliang Chen. (2024) Rapid and highly potent humoral responses to mpox nanovaccine candidates adjuvanted by thermostable scaffolds. Vaccine 42:8, pages 2072-2080.
Crossref
Dan Li, Cai Sun, Pengfei Zhuang & Xifan Mei. (2024) Revolutionizing SARS-CoV-2 omicron variant detection: Towards faster and more reliable methods. Talanta 266, pages 124937.
Crossref
Conglian Tan, Nian Wang, Shanshan Deng, Xiaoheng Wu, Changwu Yue, Xu Jia & Yuhong Lyu. (2023) The development and application of pseudoviruses: assessment of SARS-CoV-2 pseudoviruses. PeerJ 11, pages e16234.
Crossref
Qian Zhang, Nan Zhang, Han Xiao, Chen Wang & Lian He. (2023) Small Antibodies with Big Applications: Nanobody-Based Cancer Diagnostics and Therapeutics. Cancers 15:23, pages 5639.
Crossref
Monrat Chulanetra. (2023) Engineered Therapeutic Antibody Against SARS-CoV-2. Current Clinical Microbiology Reports 10:4, pages 222-235.
Crossref
Gege Yu, Jiamin Wang, Yao Zhang, Haofen Wu, Yueqi Wang, Yan Cui, Yuefan Yang, Xiaoqian Tang, Qi Zhang, Jianlong Wang, Jing Sun, Ran Chen, Yanru Wang & Peiwu Li. (2023) Anti-Idiotypic Nanobody Alkaline Phosphatase Fusion Protein-Triggered On–Off–On Fluorescence Immunosensor for Aflatoxin in Cereals. Journal of Agricultural and Food Chemistry.
Crossref
Zengchao Sun, Lu Wang, Lingyun Li, Yili Sun, Daizhou Zhang, Siyu Zhou, Yuying Li, Xiyang Li, Huarui Qiao, Qianqian Cui, Zhongyun Lan, Xiangjing Meng, Jianfeng Xu, Yong Geng & Yuanyuan Dai. (2023) Structure basis of two nanobodies neutralizing SARS-CoV-2 Omicron variant by targeting ultra-conservative epitopes. Journal of Structural Biology 215:3, pages 107996.
Crossref
Jianghua Yang, Jinsong Zhang, Ping Yan, Zhao Zhang, Weiyu Gao, Man Xu, Xinling Xu, Baoshan Liu & Zeliang Chen. (2023) Asymmetric Assembly and Self-Adjuvanted Antigen Delivery Platform for Improved Antigen Uptake and Antitumor Effect. Bioconjugate Chemistry 34:5, pages 856-865.
Crossref